Alcohol Related Liver Disease clinical trials

Explore recruiting alcohol related liver disease clinical trials.

Recruiting alcohol related liver disease studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Alcohol Related Liver Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effects of NNC0194-0499 alone and in combination with semaglutide, of semaglutide alone, and of cagrilintide alone and in combination with semaglutide on liver damage and alcohol use in people with alcohol-related liver disease

Germany, Greece, Bulgaria, France, Denmark, Czechia +4 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Dose-Finding, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of GSK4532990 for Steatohepatitis in Adults with Alcohol-related Liver Disease (ALD)

Denmark, Germany, Sweden, France, Spain, Italy +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Alcohol Related Liver Disease trials by city

Alcohol Related Liver Disease clinical trials

Recruiting alcohol related liver disease studies right now

Recompensation in Alcohol Related Hepatitis

Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis

Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients

Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients

Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19

PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis

Efficacy of Simvastatin in Alcoholic Liver Fibrosis

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Also recruiting in Europe

Effects of NNC0194-0499 alone and in combination with semaglutide, of semaglutide alone, and of cagrilintide alone and in combination with semaglutide on liver damage and alcohol use in people with alcohol-related liver disease

A Dose-Finding, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of GSK4532990 for Steatohepatitis in Adults with Alcohol-related Liver Disease (ALD)

Alcohol Related Liver Disease trials by city

Other conditions